James F. Marion

Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial

James F. Marion, Jerome D. Waye, Daniel H. Present et al. · The American Journal of Gastroenterology · 2008 · 288 citations

The Effect on the Fetus of Medications Used to Treat Pregnant Inflammatory Bowel-Disease Patients

David N. Moskovitz, Carol Bodian, Mark L. Chapman et al. · The American Journal of Gastroenterology · 2004 · 203 citations

Gut microbiota density influences host physiology and is shaped by host and microbial factors

Eduardo J. Contijoch, Graham J. Britton, Chao Yang et al. · eLife · 2019 · 172 citations · Full text

Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

William J. Sandborn, Joshua R. Korzenik, Bret A. Lashner et al. · Gastroenterology · 2010 · 139 citations

Medicine, Delayed-release Oral Mesalamine, Gastroenterology +5

Fistula response to methotrexate in Crohn's disease: a case series

Uma Mahadevan, James F. Marion, D. H. Present · Alimentary Pharmacology & Therapeutics · 2003 · 97 citations · Full text